Journalartikel

Platelet destruction in immune thrombocytopenia Understanding the mechanisms


AutorenlisteBakchoul, Tamam; Sachs, Ulrich J.

Jahr der Veröffentlichung2016

Seiten187-194

ZeitschriftHämostaseologie

Bandnummer36

Heftnummer3

ISSN0720-9355

DOI Linkhttps://doi.org/10.5482/HAMO-14-09-0043

VerlagThieme Publishing


Abstract
Immune thrombocytopenia (ITP) is an auto immune bleeding disorder characterized by isolated thrombocytopenia. A dysfunctional proliferation of autoreactive T cells is suggested to be responsible for the loss of tolerance to self-platelet antigens in ITP patients. Autoreactive T cells induce uncontrolled proliferation of autoantibody producing B cells leading to persistent anti-platelet autoimmunity in some ITP patients. The autoimmune response causes an increased destruction of platelets by antibody-mediated phagocytosis, complement activation but also by T cell mediated cytotoxicity. In addition, abnormalities in thrombopoiesis and insufficient platelet production due to antibody or T cell mediated megakaryocyte inhibition and destruction contribute to the pathophysiology of ITP. These various effector cell responses may account for the heterogeneity in the clinical manifestation of ITP and also, to success or failure of different treatment strategies. A better understanding of the mechanisms behind ITP will hopefully allow for better diagnostic and, particularly, therapeutic strategies in the future.



Zitierstile

Harvard-ZitierstilBakchoul, T. and Sachs, U. (2016) Platelet destruction in immune thrombocytopenia Understanding the mechanisms, Hämostaseologie, 36(3), pp. 187-194. https://doi.org/10.5482/HAMO-14-09-0043

APA-ZitierstilBakchoul, T., & Sachs, U. (2016). Platelet destruction in immune thrombocytopenia Understanding the mechanisms. Hämostaseologie. 36(3), 187-194. https://doi.org/10.5482/HAMO-14-09-0043



Schlagwörter


ANTIPLATELET ANTIBODIESAUTOIMMUNE-DISEASESBONE-MARROWCOMPLEMENT ACTIVATIONCONTROLLED-TRIALDOUBLE-BLINDFC-GAMMA-RIIAHELICOBACTER-PYLORIMONOCLONAL-ANTIBODYPLATELET

Zuletzt aktualisiert 2025-02-04 um 01:45